Close

Aytu BioScience (AYTU) Names Richard Eisenstadt CFO

Go back to Aytu BioScience (AYTU) Names Richard Eisenstadt CFO

Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial Officer

April 5, 2021 8:01 AM EDT

ENGLEWOOD, CO / ACCESSWIRE / April 5, 2021 / Aytu BioPharma, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the appointment of Richard Eisenstadt as Chief Financial Officer. Mr. Eisenstadt is an accomplished pharmaceutical industry executive with more than 20 years of experience in leading finance and accounting operations, supporting clinical development and commercialization, and raising capital within the life sciences sector.

Mr. Eisenstadt replaces David Green who has stepped down as Chief Financial Officer as of March 31, 2021.

Mr. Eisenstadt most recently was Chief Financial Officer... More